Andelyn Biosciences, Inc.

Andelyn Biosciences, Inc.

Andelyn Biosciences is a full-service cell and gene therapy CDMO focused on the development, characterization and production of viral vectors for gene therapy. With more than 20 years of experience, Andelyn’s deep scientific expertise has resulted in the production of cGMP material for more than 450 clinical batches and 75 global clinical trials. Operating out of its development and manufacturing facilities in Columbus, Ohio, Andelyn supports its clients in developing cell and gene therapies from concept through plasmid engineering and manufacturing, process and analytical development, and cGMP clinical and commercial manufacturing. Andelyn can accelerate programs and deliver high quality products by developing and manufacturing processes on its configurable, data-driven AAV Curator® Platform, or tech transferring in an established client program. Capabilities include cGMP manufacturing for suspension processes up to a 2,000-liter and adherent processes. A rigorous quality system, regulatory support, and supply chain vertical integration further support clients in bringing their critical therapies to market. For more information, visit andelynbio.com.

09/01/2020

Cell Therapy, Gene Therapy, Innovation Lab/R&D, Rare Disease, Cell Banking, Cell Line Development, Cell Processing, Cell Product Manufacturing, Fill & Finish, Gene Therapy, Plasmids, Small Molecule, Toxicology, Viral Vector Manufacturing - Adeno-Associated Virus, Viral Vector Manufacturing - Adenovirus, Viral Vector Manufacturing - Lentivirus